Literature DB >> 19786143

Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection.

Maria Paulke-Korinek1, Pamela Rendi-Wagner, Michael Kundi, Brigitte Laaber, Ursula Wiedermann, Herwig Kollaritsch.   

Abstract

Five and 6 years post-booster, immunity to tick-borne encephalitis (TBE) virus was assessed in 225 and 195 vaccinees, respectively, out of 430 healthy volunteers with at least three TBE-immunizations prior to study inclusion and booster intervals exceeding recommended limits. Neutralizing antibody titers of > or = 1:10 (reliable level of protection) were present in 86-96% depending on age group, with lower percentages in participants >60 years. TBE antibody levels remained stable for many years in most vaccinees. However, in a few persons a shorter period of protection against TBE was indicated. Therefore, recommendations on booster intervals in TBE endemic areas should be adapted by weighting the risk of infection against the risk of short-lived immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786143     DOI: 10.1016/j.vaccine.2009.09.068

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Mechanistic insights into the impairment of memory B cells and antibody production in the elderly.

Authors:  Judith H Aberle; Karin Stiasny; Michael Kundi; Franz X Heinz
Journal:  Age (Dordr)       Date:  2012-01-27

2.  TBE--update on vaccination recommendations for children, adolescents, and adults.

Authors:  Tomas Jelinek
Journal:  Wien Med Wochenschr       Date:  2012-06-12

3.  Tick-borne encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE).

Authors:  Zsuzsanna Jelenik; Michael Keller; Benjamin Briggs; Göran Günther; Mats Haglund; Henrieta Hudeckova; Eva Jilkova; Aukse Mickiene; Birger Sandell; Robert Steffen; Franz Strle
Journal:  Wien Med Wochenschr       Date:  2010-05

4.  Tick-Borne Encephalitis Virus Nonstructural Protein 1 IgG Enzyme-Linked Immunosorbent Assay for Differentiating Infection versus Vaccination Antibody Responses.

Authors:  P Girl; M Bestehorn-Willmann; S Zange; J P Borde; G Dobler; H von Buttlar
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

5.  Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients.

Authors:  Nicole Harrison; Katharina Grabmeier-Pfistershammer; Alexandra Graf; Ilse Schwarzinger; Judith H Aberle; Karin Stiasny; Hildegard Greinix; Werner Rabitsch; Peter Kalhs; Michael Ramharter; Heinz Burgmann; Christina Forstner
Journal:  NPJ Vaccines       Date:  2020-07-24       Impact factor: 7.344

6.  Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.

Authors:  Pontus Lindblom; Peter Wilhelmsson; Linda Fryland; Andreas Matussek; Mats Haglund; Johanna Sjöwall; Sirkka Vene; Dag Nyman; Pia Forsberg; Per-Eric Lindgren
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

7.  Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules.

Authors:  Marco Costantini; Andrea Callegaro; Jiří Beran; Valérie Berlaimont; Ilaria Galgani
Journal:  Hum Vaccin Immunother       Date:  2020-01-17       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.